Evidence map›Paper›PMID 34812647›Full record

ArticleScience immunology2022

Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion.

Valeria Fumagalli, Micol Ravà, Davide Marotta, Pietro Di Lucia, Chiara Laura, Eleonora Sala, Marta Grillo, Elisa Bono, Leonardo Giustini, Chiara Perucchini and 12 more

Abstract read
In one paragraph

Article in Science immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Valeria FumagalliDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-2583-2498
Micol RavàDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0001-7606-8368
Davide MarottaDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-1918-050X
Pietro Di LuciaDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-0726-1532
Chiara LauraDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-3949-2538
Eleonora SalaDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0001-5109-6362
Marta GrilloDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0001-9064-2274
Elisa BonoDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Leonardo GiustiniDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-3462-7891
Chiara PerucchiniDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-3010-8576
Marta MainettiDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-0113-2422
Alessandro SessaDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-3611-5056
José M Garcia-ManteigaCenter for Omics Sciences, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-5481-040X
Lorena DonniciINGM - Istituto Nazionale di Genetica Molecolare "Romeo ed Erica Invernizzi", Milan, Italy.ORCID 0000-0002-9153-9102
Lara ManganaroINGM - Istituto Nazionale di Genetica Molecolare "Romeo ed Erica Invernizzi", Milan, Italy.
Serena DelbueDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Italy.ORCID 0000-0002-3199-9369
Vania BroccoliDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-4050-0926
Raffaele De FrancescoINGM - Istituto Nazionale di Genetica Molecolare "Romeo ed Erica Invernizzi", Milan, Italy.ORCID 0000-0001-8754-5123
Patrizia D'AdamoDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-0312-5541
Mirela KukaDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0001-9418-1559
Luca G GuidottiDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-0205-2678
Matteo IannaconeDivision of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-9370-2671

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of a tractable small animal model faithfully reproducing human coronavirus disease 2019 pathogenesis would arguably meet a pressing need in biomedical research. Thus far, most investigators have used transgenic mice expressing the human ACE2 in epithelial cells (K18-hACE2 transgenic mice) that are intranasally instilled with a liquid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suspension under deep anesthesia. Unfortunately, this experimental approach results in disproportionate high central nervous system infection leading to fatal encephalitis, which is rarely observed in humans and severely limits this model’s usefulness. Here, we describe the use of an inhalation tower system that allows exposure of unanesthetized mice to aerosolized virus under controlled conditions. Aerosol exposure of K18-hACE2 transgenic mice to SARS-CoV-2 resulted in robust viral replication in the respiratory tract, anosmia, and airway obstruction but did not lead to fatal viral neuroinvasion. When compared with intranasal inoculation, aerosol infection resulted in a more pronounced lung pathology including increased immune infiltration, fibrin deposition, and a transcriptional signature comparable to that observed in SARS-CoV-2–infected patients. This model may prove useful for studies of viral transmission, disease pathogenesis (including long-term consequences of SARS-CoV-2 infection), and therapeutic interventions.

Indexed as

Disease Models, AnimalNasal SpraysAdministration, InhalationAngiotensin-Converting Enzyme 2AnimalsCOVID-19Encephalitis, ViralEpithelial CellsFemaleHumansKeratin-18LungMaleMiceMice, TransgenicPromoter Regions, GeneticACE2 protein, humanAngiotensin-Converting Enzyme 2Keratin-18Nasal Sprays

Identifiers

PMID34812647
PMCPMC9835999

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.